Established in 2017, we are dedicated to transforming healthcare through innovative medical technology and clinical excellence. Our mission is clear: to excel in the diagnosis and treatment of diseases, particularly in the realm of cancer research. We are proud to be at the forefront of developing leading cancer research hospitals, with a commitment to pushing the boundaries of medical science.

Our Commitment to Patient-Centric Care

At GoBroad, we believe that effective cancer treatment begins with patient-centric care. Our cancer research hospitals are designed not only to treat but to understand the unique needs of each patient. By combining clinical treatment with extensive research, we ensure that every patient benefits from the latest advancements in medical science. Our multidisciplinary healthcare teams work collaboratively to provide personalized care, focusing on innovative therapies such as immunotherapy and targeted treatments. This holistic approach is what sets our cancer research hospitals apart, allowing us to deliver remarkable outcomes for our patients.

Innovative Research and Clinical Excellence

As a pioneer of the research-oriented hospital model in China, GoBroad is committed to fostering innovation within our cancer research hospitals. Our unique Academic Research Organization (ARO) strategy integrates clinical discovery with basic research, ensuring that our treatments are grounded in the latest scientific findings. With nearly 1,500 beds across seven hospitals in major cities like Beijing, Shanghai, and Guangzhou, we are equipped to conduct groundbreaking clinical trials and offer cutting-edge therapies. Our focus on solid tumors, hematological diseases, and brain science positions us as leaders in cancer research, providing hope and new treatment options to those facing severe diseases.

Leading the Way in Advanced Therapies

At GoBroad, we are proud to be national leaders in several advanced cancer therapies, including adoptive cell therapy and CAR-T therapy. Our team of experts has extensive experience in these innovative treatments, which have shown incredible promise in the fight against cancer. Our research-oriented cancer research hospitals are equipped with state-of-the-art facilities, including a central laboratory and an early-stage clinical research center. This allows us to not only conduct vital research but also to translate those findings into practical applications for our patients. By emphasizing technological innovation, we strive to enhance the quality of care and improve patient outcomes.

Conclusion

In conclusion, GoBroad Healthcare Group is dedicated to building a network of leading cancer research hospitals that prioritize patient needs and embrace innovation. Our commitment to excellence in clinical research and treatment is unwavering, as we continue to serve patients with severe diseases that are challenging to treat. Through our advanced therapies and patient-centric approach, we are not just providing treatment; we are offering hope.